Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced today that it will host …